The purpose of this post-approval study is to evaluate the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods.

Cardiac PacemakerArrythmiaBradycardia

~Estimated

~$10 – $1,125

Abbott Medical DevicesNCT05935007

The AVEIR DR Coverage With Evidence Development (DRIVE) Study

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the dual chamber Aveir Leadles…

Cardiac PacemakerArrythmiaBradycardia

~Estimated

~$10 – $1,125

Abbott Medical DevicesNCT05932602

Aveir Single-Chamber Leadless Pacemaker Coverage With Evidence Development (ACED) Post-Approval Study

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Singl…

Cardiac PacemakerArrythmiaBradycardia

~Estimated

~$10 – $1,125

Abbott Medical DevicesNCT05336877

Aveir AR Coverage With Evidence Development (CED) Study

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Atria…

Cardiac PacemakerArrhythmiaBradycardia

~Estimated

~$10 – $1,125

Abbott Medical DevicesNCT06100770